drugset / Trial / NCT05553132

A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects

NCT05553132

Phase 1 Active not recruiting 15 enrolled Daniel B. F. Saris
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study it to gather information on the safety and side effects of treating cartilage defects with autologous cartilage cells mixed with allogeneic adipose-derived mesenchymal stem cells (AMSCs) in a fibrin glue.

Timeline

Start
2023-08-08
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogeneic Adipose-Derived Mesenchymal Stromal Cells Cell therapy
Subject autologous chondrocytes Cell therapy
Background Fibrinogen Concentrate Human Protein / enzyme biologic